Skip to main content
峆一药业 logo

峆一药业 — Investor Relations & Filings

Ticker · 920478 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 363 across all filing types
Latest filing 2023-12-11 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920478

About 峆一药业

http://www.heryipharma.com/

Anhui Heyi Pharmaceutical Co., Ltd. specializes in the research, development, production, and sales of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company focuses on providing high-quality chemical products for various therapeutic areas, including cardiovascular, central nervous system, and anti-infective treatments. With a strong emphasis on technological innovation and quality control, it operates advanced manufacturing facilities that adhere to international standards. Its product portfolio includes key intermediates for widely used medications, supporting both domestic and global pharmaceutical supply chains. The company leverages its expertise in complex chemical synthesis to offer customized solutions and reliable supply to its partners in the life sciences sector.

Recent filings

Filing Released Lang Actions
董事任命公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new director to the company's board. It details the nomination, qualifications, and legal compliance of the new director, as well as the impact on the company's governance. There is no financial data, no report or presentation attached, and it is not a regulatory certification or voting result. The content clearly fits the category of Board/Management Information, which covers announcements of changes in the company's board of directors or senior management.
2023-12-11 Chinese
董事会提名委员会议事规则
Governance Information Classification · 95% confidence The document is titled as the "安徽峆一药业股份有限公司董事会提名委员会议事规则" which translates to "Rules of Procedure for the Board Nomination Committee of Anhui Xuyi Pharmaceutical Co., Ltd.". It details the composition, responsibilities, and procedures of the board nomination committee. There is no financial data, no mention of financial results, no voting results, no announcements of reports, or any other regulatory filings. The content is focused on governance structure and internal rules related to the board nomination committee. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is 2682 characters, which is sufficient for a detailed governance document. Therefore, the classification is CGR with high confidence.
2023-12-11 Chinese
职工代表监事辞职公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the resignation of a company's employee representative supervisor (监事) and the subsequent election to fill the vacancy. It details the resignation reason, impact on the board composition, and confirms compliance with legal requirements. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to annual or interim reports. The content focuses on changes in the company's supervisory board members, which fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS.
2023-12-06 Chinese
监事辞职公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a company supervisor (监事) from the supervisory board. It details the resignation date, reasons, and the impact on the company's board composition and operations. There is no financial data, no mention of financial results, no regulatory filings about financial performance, and no indication of a report being attached or published. This is a clear announcement about a change in the company's board or senior management structure. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on this personnel change, confirming the classification.
2023-12-06 Chinese
职工代表监事任命公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new supervisor (监事) in the company Anhui Xuyi Pharmaceutical Co., Ltd. It details the resignation of a previous supervisor and the election and appointment of a new one, including their qualifications and the impact of this appointment on the company. There are no financial statements, earnings data, or report publications. The content clearly relates to changes in the company's board or senior management structure. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on management changes, confirming this classification with high confidence.
2023-12-06 Chinese
2023年第一次职工代表大会决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolution from the company's first employee representative meeting in 2023. It details the meeting date, attendance, and the approval of a proposal to elect a new employee representative supervisor. There is no financial data, no mention of annual or quarterly reports, no audit information, no earnings data, and no regulatory filings related to financial performance. The content focuses on internal governance matters related to the election of a supervisory board member representing employees. This fits the category of Board/Management Information (MANG), which includes announcements of changes in the company's board or senior management. The document is short and formal, consistent with a management or board announcement rather than a full report or regulatory filing.
2023-12-06 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.